TOMI Secures $450,000 Contract for Custom Engineered System (CES) Installation

Rhea-AI Summary

TOMI Environmental Solutions (NASDAQ: TOMZ) has secured a significant $450,000 contract to install a SteraMist iHP Custom Engineered System (CES) at a leading Rhode Island university. The contract, secured through distributor ARES Distribution, demonstrates TOMI's competitive edge over hydrogen peroxide competitors.

The company is also in negotiations with a long-standing Boston client for a CES upgrade and expansion project. Earlier this quarter, TOMI added a SteraPak system sale at a Massachusetts private university. The company's New England territory portfolio now includes over 20 biotechnology, pharmaceutical, and research university customers.

TOMI's Binary Ionization Technology® (BIT™) platform, originally developed under a DARPA defense grant, uses ionized Hydrogen Peroxide (iHP™) technology for superior disinfection and decontamination solutions.

Positive

• Secured new $450,000 contract for CES installation
• Potential expansion deal with existing Boston client
• Recent SteraPak system sale in Massachusetts
• Strong regional presence with 20+ customers in New England

Negative

• None.

Insights

Financial Analyst

TOMI Environmental Solutions has secured a $450,000 contract for its SteraMist iHP Custom Engineered System (CES) at a Rhode Island university, representing a significant win for this $18M market cap company. This contract value equals approximately 2.5% of TOMI's market capitalization, making it a material revenue event for a company of this size.

The competitive victory over other hydrogen peroxide systems providers demonstrates TOMI's technological differentiation in the disinfection market. This win through their distribution partner ARES Distribution also validates their go-to-market strategy and channel development efforts.

Beyond the immediate revenue impact, the announcement contains several positive forward indicators: negotiations with a longstanding Boston client for an upgrade/expansion project, a recent SteraPak system sale to a Massachusetts university, and reference to their established regional presence with over 20 biotechnology, pharmaceutical, and research university customers.

For a small-cap company like TOMI, establishing footprint in the academically dense New England region provides both immediate revenue and potential for repeat business through system expansions, consumables, and service contracts. The specific mention of Boston's life science industry anticipating a 2025 rebound suggests TOMI is positioning itself to capitalize on increased sector spending.

This contract represents meaningful progress in commercial execution for a company of TOMI's size and validates their competitive position in institutional disinfection and decontamination markets.

FREDERICK, Md., March 24, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced a significant contract to install a SteraMist iHP Custom Engineered System (CES) at a leading university in Rhode Island, valued at approximately $450,000. This new client was secured through our distributor, ARES Distribution, and underscores TOMI’s competitive advantage, having successfully outperformed key hydrogen peroxide competitors.

This contract further emphasizes the effectiveness and adaptability of TOMI’s SteraMist technology. Additionally, TOMI is in negotiations with a long-standing client in Boston, an early adopter of CES, for a potential upgrade and expansion project. There is clear demand among academic institutions for enhanced decontamination solutions, as TOMI’s cutting-edge technology continues to demonstrate superior performance compared to traditional hydrogen peroxide systems.

As Boston's life science industry anticipates a rebound in 2025, TOMI’s SteraMist iHP technology is poised to remain a preferred choice for disinfection requirements. Earlier this quarter, TOMI secured another sale with the addition of a SteraPak system at a private university in Massachusetts. The recent university contract adds to our impressive portfolio in the New England territory, which includes over twenty (20) separate biotechnology, pharmaceutical, and research university customers.

"We are thrilled to see the continued adoption and expansion of SteraMist technology in New England, a region renowned for its concentration of life science innovation and world-class educational and research institutions," said Elissa J. (E.J.) Shane, COO of TOMI Environmental Solutions. "These orders, and those to come, not only validate the efficacy of our solutions but also reflect our commitment to providing cutting-edge disinfection technologies to support the critical work being done in these American institutions."

TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.

For additional information, please visit http://www.steramist.com or contact us at info@tomimist.com

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products to serve life science markets in New England. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com

FAQ

What is the value of TOMI's latest CES installation contract?

TOMI (TOMZ) secured a $450,000 contract for a SteraMist iHP Custom Engineered System installation at a Rhode Island university.

How many customers does TOMI have in the New England territory?

TOMI (TOMZ) has over 20 customers in New England, including biotechnology, pharmaceutical, and research university clients.

What recent sales has TOMI (TOMZ) secured in Massachusetts?

TOMI recently sold a SteraPak system to a private university in Massachusetts and is negotiating a CES upgrade with a Boston client.

What technology does TOMI's SteraMist system use?

TOMI's SteraMist uses Binary Ionization Technology (BIT) with ionized Hydrogen Peroxide (iHP) technology, developed under a DARPA defense grant.